Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

DRL's Andhra Pradesh facility gets 3 observations from USFDA

Dr Reddy's Laboratories said that the US drug regulator has issued Form 483, with three observations after inspecting its Andhra Pradesh manufacturing facility.

By: business-standard.com

Aug 24 2024
0
0 Views

DRL's Andhra Pradesh facility gets 3 observations from USFDA

Related

DRL's Andhra Pradesh facility gets 3 observations from USFDA

SNS Properties & Leasing reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Rathi Industries reports standalone net profit of Rs 1.25 crore in the June 2024 quarter

Aashrit Capital reports standalone net loss of Rs 0.29 crore in the June 2024 quarter

Lohia Securities consolidated net profit rises 87.56% in the June 2024 quarter

E I T A India standalone net profit declines 25.74% in the June 2024 quarter

Data Infrastructure Trust consolidated net profit declines 29.50% in the June 2024 quarter

Rakan Steels standalone net profit declines 50.00% in the June 2024 quarter

Jagat Trading Enterprises reports standalone net profit of Rs 0.21 crore in the June 2024 quarter

Supreme Commercial Enterprises reports consolidated net profit of Rs 0.03 crore in the June 2024 quarter

Zydus Life arm inks pact to acquire 50% stake in Sterling Biotech

Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

SNS Properties & Leasing reports standalone net loss of Rs 0.02 crore in the June 2024 quarter